Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Funding Amount
Up to $100,000
Deadline
March 16, 2029
890 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Nonprofits without 501(c)(3) status
- Tribal governments
- Private colleges & universities
- Public colleges & universities
- Small businesses
- Special district governments
- State governments
- City & township governments
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
Science Track Award for Research Transition (START) Program
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by providing seed funding for projects that build expertise and enable research at the intersection of substance use research and one or more of the following fields: Discovery and development of new chemical entities or biologics to advance therapeutic interventions for substance use disorders (SUDs) and drug dependence Development and application of brain imaging tools or brain imaging methods Application of innovative neurocognitive and behavioral science tools or paradigms Application of advanced data science techniques and innovative computational methods, including artificial intelligence Research that can lead to advancing basic, clinical, translational, epidemiological, or intervention science regarding substance use and HIV/AIDS Projects funded by the Science Track Award for Research Transition (START) program are expected to yield findings that will lead to new concepts or guide the design of more comprehensive studies and serve as preliminary data for a larger R or equivalent applications. Early stage and new investigators, as well as investigators new to substance use or AIDS research, are encouraged to apply. Grant Authorities that allow NIDA to forecast this opportunity are as follows: Section 301 (42 U.S.C. § 241) and Section 405 (42 U.S.C. § 284).
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAS-26-035
- Instrument: grant
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Science research
- Addiction recovery
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional). Now let's win it.